Bretaris Genuair vs Tiotropium: Side-by-Side Comparison
Quick answer: Bretaris Genuair and Tiotropium are both long-acting muscarinic antagonist (lama) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Bretaris Genuair | Tiotropium |
|---|---|---|
| Drug class | Long-acting muscarinic antagonist (LAMA) | Long-acting muscarinic antagonist (LAMA) |
| ATC code | R03BB05 | R03BB04 |
| Primary indications | Chronic obstructive pulmonary disease (COPD) | COPD, Asthma |
| Mechanism | Brand name for aclidinium bromide via Genuair inhaler; long-acting anticholinergic bronchodilator | Long-acting anticholinergic that blocks M3 muscarinic receptors causing bronchodilation |
| Common dose | 322 mcg (one inhalation) twice daily | 18 mcg inhaled once daily (HandiHaler) or 2.5 mcg x2 puffs (Respimat) |
| Detail page | Bretaris Genuair details → | Tiotropium details → |
How to choose between Bretaris Genuair and Tiotropium
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Long-acting muscarinic antagonist (LAMA) on iMedic · Bretaris Genuair full details · Tiotropium full details
Frequently asked questions
Is Bretaris Genuair better than Tiotropium?
Neither is universally 'better.' They are both long-acting muscarinic antagonist (lama) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Bretaris Genuair to Tiotropium?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Bretaris Genuair and Tiotropium have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Bretaris Genuair and Tiotropium available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.